Drugs.com - Pharma Industry News

Semaglutide Ups Risk for Nonarteritic Anterior Ischemic Optic Neuropathy in Diabetes

TUESDAY, April 8, 2025 -- For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic neuropathy (NAION), according to a study published online March 27 in JAMA Ophthalmology.Alan Y...

Apr 8, 2025 - 18:32
 0
Semaglutide Ups Risk for Nonarteritic Anterior Ischemic Optic Neuropathy in Diabetes
TUESDAY, April 8, 2025 -- For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic neuropathy (NAION), according to a study published online March 27 in JAMA Ophthalmology.Alan Y...
Read More

Tags:

Previous Article

Narrowband UVB Phototherapy Underused for Pediatric Vitiligo

Next Article

Globally, One in 13 Youth Experience Nocturnal Enuresis

Related Posts

AAAAI: Omalizumab Superior to Oral Immunotherapy in Multifood Allergy

AAAAI: Omalizumab Superior to Oral Immunotherapy in Mul...

Mar 3, 2025  0

Short-Term Limited Duration Insurance Plans Tied to Increase in Late-Stage Cancer Diagnoses

Short-Term Limited Duration Insurance Plans Tied to Inc...

Mar 21, 2025  0

Racial, Ethnic Minorities Still Underrepresented in Int...

Feb 9, 2025  0